Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-06-26 5:16 pm Sale | 13D | Ventyx Biosciences Inc. VTYX | NSV Investments I L.P. | 7,102,969 10.1% | -1,336,666![]() (-15.84%) | View |
2024-04-04 12:52 pm Purchase | 13G | Ventyx Biosciences Inc. VTYX | Flynn James E | 3,542,000 5.03% | 3,542,000![]() (New Position) | View |
2024-03-21 4:02 pm Purchase | 13G | Ventyx Biosciences Inc. VTYX | Cormorant Asset Management LP | 3,670,000 5.21% | 3,670,000![]() (New Position) | View |
2024-03-13 6:04 pm Unchanged | 13D | Ventyx Biosciences Inc. VTYX | NSV Investments I L.P. | 8,439,635 12% | 0 (Unchanged) | View |
2024-03-08 4:05 pm Sale | 13D | Ventyx Biosciences Inc. VTYX | NSV Investments I L.P. | 8,439,635 14.2% | -117,231![]() (-1.37%) | View |
2024-02-23 4:28 pm Purchase | 13G | Ventyx Biosciences Inc. VTYX | Point72 Asset Management L.P. | 3,017,093 5.1% | 3,017,093![]() (New Position) | View |
2024-02-14 4:57 pm Purchase | 13G | Ventyx Biosciences Inc. VTYX | CITADEL ADVISORS LLC | 4,279,553 7.3% | 490,758![]() (+12.95%) | View |
2024-02-13 5:16 pm Purchase | 13G | Ventyx Biosciences Inc. VTYX | VANGUARD GROUP INC | 3,741,925 6.34% | 3,741,925![]() (New Position) | View |
2024-01-29 4:00 pm Purchase | 13G | Ventyx Biosciences Inc. VTYX | TANG CAPITAL PARTNERS LP | 3,100,000 5.2% | 3,100,000![]() (New Position) | View |
2024-01-29 3:26 pm Purchase | 13G | Ventyx Biosciences Inc. VTYX | BlackRock Inc. BLK | 3,814,531 6.5% | 3,814,531![]() (New Position) | View |
2023-12-11 09:09 am Sale | 13G | Ventyx Biosciences Inc. VTYX | FMR LLC | 322,615 0.546% | -7,281,726![]() (-95.76%) | View |
2023-07-19 5:03 pm Purchase | 13D | Ventyx Biosciences Inc. VTYX | NSV Investments I L.P. | 8,556,866 14.6% | 34,242![]() (+0.40%) | View |
2023-07-11 4:02 pm Sale | 13D | Ventyx Biosciences Inc. VTYX | NSV Investments I L.P. | 8,522,624 14.6% | -1,554,421![]() (-15.43%) | View |
2023-04-10 09:37 am Purchase | 13G | Ventyx Biosciences Inc. VTYX | FMR LLC | 7,604,341 13.062% | 7,604,341![]() (New Position) | View |
2023-04-07 5:13 pm Sale | 13D | Ventyx Biosciences Inc. VTYX | NSV Investments I L.P. | 10,077,045 17.3% | -1,747,098![]() (-14.78%) | View |
2023-03-22 3:45 pm Sale | 13D | Ventyx Biosciences Inc. VTYX | NSV Investments I L.P. | 11,824,143 20.9% | -1,150,643![]() (-8.87%) | View |
2023-03-02 4:56 pm Unchanged | 13D | Ventyx Biosciences Inc. VTYX | NSV Investments I L.P. | 12,974,786 22.9% | 0 (Unchanged) | View |
2023-02-14 08:02 am Sale | 13G | Ventyx Biosciences Inc. VTYX | CITADEL ADVISORS LLC | 3,788,795 6.7% | -102,278![]() (-2.63%) | View |
2023-01-30 5:25 pm Sale | 13D | Ventyx Biosciences Inc. VTYX | venBio Global Strategic Fund III L.P. | 2,720,994 4.8% | -749,502![]() (-21.60%) | View |
2022-12-30 5:05 pm Unchanged | 13D | Ventyx Biosciences Inc. VTYX | NSV Investments I L.P. | 12,974,786 22.9% | 0 (Unchanged) | View |